# Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension

Study · id `cardio:ct-nct06212648` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06212648](<https://clinicaltrials.gov/study/NCT06212648>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06212648

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 253 participants.

## Technical summary

Registry record NCT06212648. Randomized; double masking; primary purpose treatment. Start 2022-03-25 (actual); primary completion 2022-11-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 253 participants (enrolled count; ClinicalTrials.gov record NCT06212648, source copy `cardio:ctgov-nct06212648-2024-01-19`, retrieved 2026-10-26)
- Started: 2022-03-25 (actual) (ClinicalTrials.gov record NCT06212648, source copy `cardio:ctgov-nct06212648-2024-01-19`, retrieved 2026-10-26)
- Primary completion: 2022-11-27 (actual) (ClinicalTrials.gov record NCT06212648, source copy `cardio:ctgov-nct06212648-2024-01-19`, retrieved 2026-10-26)
- Completion: 2023-01-27 (actual) (ClinicalTrials.gov record NCT06212648, source copy `cardio:ctgov-nct06212648-2024-01-19`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT06212648, source copy `cardio:ctgov-nct06212648-2024-01-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06212648-2024-01-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension
- Acronym: SP-CAP-002
- Condition: Hypertension
- Condition: Essential Hypertension
- Intervention (Drug): SPC1001 High
- Intervention (Drug): SPC1001 Mid1
- Intervention (Drug): SPC1001 Mid2
- Intervention (Drug): SPC1001 Low
- Intervention (Drug): SPC3001
- Intervention (Drug): SPC4001
- Intervention (Drug): SPC4002
- Intervention (Drug): Placebo
- Lead sponsor: Shin Poong Pharmaceutical Co. Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Shin Poong Pharmaceutical Co. Ltd. (`cardio:org-shin-poong-pharmaceutical-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension (`cardio:pubmed-41162308`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e47f57dd0e9d55578dd3ed04cc200c5f26f96e90fb18b1b17b1260523ed5178b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
